These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 11051345)

  • 61. Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.
    Huang AH; Sheu BS; Yang HB; Huang CC; Wu JJ; Lin XZ
    J Formos Med Assoc; 2000 Sep; 99(9):704-9. PubMed ID: 11000734
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate.
    Choi HS; Park DI; Hwang SJ; Park JS; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
    Helicobacter; 2007 Dec; 12(6):638-42. PubMed ID: 18001407
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies.
    Malfertheiner P; Kirchner T; Kist M; Leodolter A; Peitz U; Strobel S; Bohuschke M; Gatz G;
    Aliment Pharmacol Ther; 2003 May; 17(9):1125-35. PubMed ID: 12752349
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Triple therapy with pantoprazole, clarithromycin and amoxicillin for eradication in patients with Helicobacter pylori positive duodenal ulcers.
    Ghazzawi IM; Obeidat WA; Zuriekat FA
    Saudi Med J; 2004 Aug; 25(8):1006-9. PubMed ID: 15322588
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The efficacy of the third pump inhibitor--pantoprazole--in the short-term treatment of Chinese patients with duodenal ulcer.
    Chen TS; Chang FY; Ng WW; Lee FY; Hwang SJ; Lee SD
    Hepatogastroenterology; 1999; 46(28):2372-8. PubMed ID: 10522000
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.
    Miwa H; Ohkura R; Murai T; Sato K; Nagahara A; Hirai S; Watanabe S; Sato N
    Aliment Pharmacol Ther; 1999 Jun; 13(6):741-6. PubMed ID: 10383502
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
    Vallve M; Vergara M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1149-56. PubMed ID: 12030958
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [A prospective study on rabeprazole-based triple therapy for Helicobacter pylori eradication in patients with peptic ulcer].
    Choi BK; Yang SY; Park ET; Jang YS; Lee YJ; Lee SH; Seol SY; Chung JM
    Korean J Gastroenterol; 2003 Aug; 42(2):102-7. PubMed ID: 14532713
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
    Kato S; Takeyama J; Ebina K; Naganuma H
    Pediatrics; 1997 Jul; 100(1):E3. PubMed ID: 9200377
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
    Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
    Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia].
    Buzás GM
    Orv Hetil; 2004 Oct; 145(42):2141-5. PubMed ID: 15566071
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.
    Niv Y
    Dig Dis Sci; 2005 May; 50(5):839-41. PubMed ID: 15906754
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.
    Perri F; Festa V; Merla A; Barberani F; Pilotto A; Andriulli A
    Aliment Pharmacol Ther; 2003 Oct; 18(8):815-20. PubMed ID: 14535875
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antibiotic-resistance patterns of Helicobacter pylori in Croatia: cohort study.
    Rosandić M
    Croat Med J; 2001 Feb; 42(1):45-8. PubMed ID: 11172654
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?
    O'Connor HJ; McLoughlin R; Kelly S; Laundon J; Cunnane K
    Aliment Pharmacol Ther; 1998 Mar; 12(3):273-6. PubMed ID: 9570262
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Resolution of granulomatous rosacea after eradication of Helicobacter pylori with clarithromycin, metronidazole and pantoprazole.
    Mayr-Kanhäuser S; Kränke B; Kaddu S; Müllegger RR
    Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1379-83. PubMed ID: 11692067
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradication.
    Bardhan KD; Morton D; Slater DN; Perry MJ; Cherian P; Jones RB; Brookes A; Thompson M; Morris P; McCaldin B
    Aliment Pharmacol Ther; 1998 Feb; 12(2):185-9. PubMed ID: 9692693
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients.
    Shimoyama T; Munakata A; Mizuki I; Akagi T; Fukuda S; Ohkawa K; Yoshida Y; Aisawa T; Sakata Y; Fukushi M
    J Clin Gastroenterol; 1995; 20 Suppl 2():S125-7. PubMed ID: 7594328
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics of clarithromycin in Helicobacter pylori eradication therapy in patients with liver cirrhosis.
    Azuma T; Ito S; Suto H; Ito Y; Miyaji H; Yamazaki Y; Kato T; Kuriyama M
    Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():216-22. PubMed ID: 10807427
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
    Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
    World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.